Tesamorelin Price: Cost per mg and per Week
What Tesamorelin costs per mg by vial size, from dated public listings. No vendor links, no coupons.
Price per mg
Why prices vary
- Brand-name prices depend on insurance coverage, manufacturer programs and pharmacy; compounded versions are priced differently.
- Bigger vials usually cost less per mg, but only if the whole vial is used before it expires.
- Prices change often, which is why every figure here carries the date it was checked.
Price data
The price file has 0 observation rows for tesamorelin, so no price is published.
Calculated from raw observation rows 0; min distinct sellers 3; dataset checked 2026-10-02. Formula: published sizes = sizes with at least 3 distinct sellers whose price was still on the page at the re-fetch; rows counted in research/sourced/market/prices/observations.csv
Regulatory status
Drugs@FDA lists tesamorelin as Egrifta, a prescription powder supplied in a vial.[2]
WADA's Prohibited List names tesamorelin among the GHRH analogues under S2.2.4.[1]
What studies found
In a randomized trial in patients with HIV and abdominal fat accumulation, visceral adipose tissue fell 15.2% with tesamorelin and rose 5.0% with placebo.[5]
Common questions
How much does Tesamorelin cost?
We publish price per mg only from dated, public listings. We have not collected enough listings for Tesamorelin to publish a figure. We never link to sellers.
Where can I buy Tesamorelin?
The approved product is available by prescription from a pharmacy. We don't link to or rank online sellers.
tesamorelin for sale?
Tesamorelin is an FDA-approved prescription drug (Egrifta), listed in Drugs@FDA.[2]
tesamorelin cost per month?
No price is published for tesamorelin: a vial size is listed only when at least 3 distinct sellers have been recorded, and none has been.
Calculated from raw observation rows 0; min distinct sellers 3. Formula: published sizes require at least 3 distinct sellers
More on Tesamorelin
Sources
- 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 2United States: Approved by FDA as Egrifta (original approval 10 Nov 2010), Theratechnologies, for reduction of excess abdominal fat in HIV-infected adults with lipodystrophy (label quote).U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
- 3FDA warning letters to five research-peptide sellersFDA warning letter (NuScience Peptides; 1 of 5) · 2026fda.govAccessed 2 Oct 2026
- 4EGRIFTA WR (TESAMORELIN) KIT [THERATECHNOLOGIES INC.]FDA label (Egrifta WR), DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
- 5Metabolic effects of a growth hormone-releasing factor in patients with HIV.The New England journal of medicine · 2007PMID 18057338Accessed 2 Oct 2026
Found an error? Report a correction.